associated with lower amputation risk 245 Diabetes 82.4% healed Minor 5 years Not reported 69±9 17.5% (1 year) aim was to Chu et al evaluate re-ulceration, 2016158 22.3% (3 year) re-amputation and 47.1% (5 year) mortality. Mortality; Risk factors for 5.8% (1 year) male 15.1% (3 year) gender, age >70 HbA1c >9%. 32.7% (5 year) 76.4% Re-ulceration in 5 years. Risk factors; ischemia, great toe amputation, HbA1c >9%. 40335 DFS 17.3% Not reported Minor and major Maximum 4 Not reported 70±12 DFS Major Study based on Malyar et al German register of 2016193 PAD + DM 72±10 health insurance. 21.5% PAD+DM 7% (DFS), 12% (PAD+DM), 9.5% PAD 61.2% 71±12 PAD (PAD). 4 year mortality: 30% Minor (DFS) 19% 39% (PAD+DM) (DFS), 12% 52% (PAD) (PAD+DM), 12% (PAD). 218 Diabetes + non 64% healed Transmetatarsal 2008-2013 Not reported Mean 67 years 33% 1 year mortality 8% Mandolfino et al diabetes 2016165 Aim of study was to define role and timing of vascular surgery 777 Diabetes Not reported 1231 minor 1996-2013 Not reported 56 (27-83) Not reported Retrospective Wilbek et al amputations DM type 1 2016197 men 5 year mortality: 52 (23-93) Type 1 DM 43%, DM type 1 Type 2 DM 52% women 66 (35-91) DM type 2 men 71 (35-97) DM type 2 women
associated with lower amputation risk Chu et al 2016158 245 Diabetes 82.4% healed Minor 5 years Not reported 69±9 17.5% (1 year) 22.3% (3 year) 47.1% (5 year) Risk factors for male gender, age >70 HbA1c >9%. aim was to evaluate re-ulceration, re-amputation and mortality. Mortality; 5.8% (1 year) 15.1% (3 year) 32.7% (5 year) Re-ulceration 76.4% in 5 years. Risk factors; ischemia, great toe amputation, HbA1c >9%. Malyar et al 2016193 40335 DFS 17.3% PAD + DM 21.5% PAD 61.2% Not reported Minor and major Maximum 4 Not reported 70±12 DFS 72±10 PAD+DM 71±12 PAD Major 7% (DFS), 12% (PAD+DM), 9.5% (PAD). Minor 19% (DFS), 12% (PAD+DM), 12% (PAD). Study based on German register of health insurance. 4 year mortality: 30% (DFS) 39% (PAD+DM) 52% (PAD) Mandolfino et al 2016165 218 Diabetes + non diabetes 64% healed Transmetatarsal 2008-2013 Not reported Mean 67 years 33% 1 year mortality 8% Aim of study was to define role and timing of vascular surgery Wilbek et al 2016197 777 Diabetes Not reported 1231 minor amputations 1996-2013 Not reported 56 (27-83) DM type 1 men 52 (23-93) DM type 1 women 66 (35-91) DM type 2 men 71 (35-97) DM type 2 women Not reported Retrospective 5 year mortality: Type 1 DM 43%, Type 2 DM 52%
170222_kappa.docx